We provide integrated services across:
Apr 11, 2025
What technology areas can we support?
We provide integrated services across:
- Autologous and allogeneic cell therapies (e.g. T cells, iPSCs, MSCs)
- Viral vectors (e.g. AAV, lentivirus, including scalable suspension processes)
- RNA technologies (e.g. mRNA, saRNA, cRNA with LNP encapsulation) We support process development, tech transfer, GMP manufacturing, and fill finish for these modalities within a single site.
Latest News
eXmoor Pharma appoints Manuel Balbuena as Chief Commercial Officer to strengthen global commercial strategy
Mar 3, 2026
Industry News
Lucy Foley appointed to BioPhorum Strategic Advisory Board
Feb 6, 2026
Industry News
Efficiency, Scale and the Role of Cohesive CMC and Manufacturing Planning
Dec 9, 2025
Blog
Let’s Accelerate Your Therapy Together
Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.